UPC Analytics
ENDE
Overview · Filed: —

UPC_APP_15/2025

REENGINEERING MRNA PRIMARY STRUCTURE FOR ENHANCED PROTEIN PRODUCTION

Procedural & sub-applicationsDocument Access (RoP262)Munich LDApplication RoP262A—
OverviewDecisionsDocumentsTimeline
  • 2025-03-10Procedural onlyproceduralApplication RoP262A

    The Munich Local Division granted Promosome LLC's application under Rule 262A RoP for confidentiality protection of certain exhibits (VB 4a and VB 4b) in its infringement action against BioNTech and Pfizer entities.

  • 2025-03-10Procedural onlyproceduralApplication RoP262A

    Munich Local Division issued a confidentiality order under Rule 262A RoP in the infringement action by BioNTech/Pfizer entities against Promosome LLC (EP 2 401 365). The order protected specific exhibits (VB 4a and VB 4b) containing confidential licensing information, granting access only to named representatives and specified individuals from each party. The preliminary protection from a prior order was lifted to the extent superseded.